Lemaitre Vascular (LMAT) Other Non-Current Liabilities (2010 - 2026)
Lemaitre Vascular (LMAT) reported Other Non-Current Liabilities of $1.3 million for Q1 2026, up 49.83% year-over-year from $875000.0 in Q1 2025, and up 160.12% quarter-over-quarter from $504000.0 in Q4 2025.
Lemaitre Vascular (LMAT) Other Non-Current Liabilities (2010 - 2026) Analysis & Trends
Lemaitre Vascular (LMAT) has 17 years of Other Non-Current Liabilities data on file, last reported at $1.3 million in Q1 2026.
- Other Non-Current Liabilities for Q1 2026 came in at $1.3 million, up 49.83% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.3 million (up 49.83% YoY), and the FY2025 annual result was $504000.0, down 11.89% from the prior year.
- Other Non-Current Liabilities climbed to $1.3 million in Q1 2026 per LMAT's latest filing, from $504000.0 in the prior quarter.
- Over five years, Other Non-Current Liabilities peaked at $2.5 million in Q2 2022 and troughed at $177000.0 in Q4 2022.
- A 5-year average of $1.1 million and a median of $632000.0 in 2024 frame the typical range for Other Non-Current Liabilities.
- The sharpest annual moves came in 2022 and 2023: Other Non-Current Liabilities sank 93.45% in 2022, then surged 1181.36% in 2023.
- A 5-year view of Other Non-Current Liabilities shows it stood at $177000.0 in 2022, then surged by 1181.36% to $2.3 million in 2023, then plunged by 74.78% to $572000.0 in 2024, then dropped by 11.89% to $504000.0 in 2025, then surged by 160.12% to $1.3 million in 2026.
- Business Quant data shows LMAT's Other Non-Current Liabilities at $1.3 million in Q1 2026, $504000.0 in Q4 2025, and $608000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn |
| 10 | Lemaitre Vascular | 2.12 Bn | 1.75 Bn | 48.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.31 Mn |
| Dec 31, 2025 | 504,000.00 |
| Sep 30, 2025 | 608,000.00 |
| Jun 30, 2025 | 311,000.00 |
| Mar 31, 2025 | 875,000.00 |
| Dec 31, 2024 | 572,000.00 |
| Sep 30, 2024 | 632,000.00 |
| Jun 30, 2024 | 242,000.00 |
| Mar 31, 2024 | 2.18 Mn |
| Dec 31, 2023 | 2.27 Mn |
| Sep 30, 2023 | 2.15 Mn |
| Jun 30, 2023 | 578,000.00 |
| Mar 31, 2023 | 628,000.00 |
| Dec 31, 2022 | 177,000.00 |
| Sep 30, 2022 | 2.41 Mn |
| Jun 30, 2022 | 2.50 Mn |
| Mar 31, 2022 | 766,000.00 |
| Dec 31, 2021 | 2.70 Mn |
| Sep 30, 2021 | 756,000.00 |
| Jun 30, 2021 | 4.55 Mn |